Researchers to launch USC’s first clinical study of psychedelic chemical psilocybin for mental health (opens in new tab)
Related News NIH investment totaling 30.7M will expand USC-led AI effort to decode Alzheimer’s disease April 2, 2026 USC study maps brain network changes linked to bipolar disorder severity and […]
Read the original article